Next Article in Journal
Visceral Adipose Tissue E2F1-miRNA206/210 Pathway Associates with Type 2 Diabetes in Humans with Extreme Obesity
Next Article in Special Issue
Analysis of the Utilization and Prospects of CRISPR-Cas Technology in the Annotation of Gene Function and Creation New Germplasm in Maize Based on Patent Data
Previous Article in Journal
Post-Translational Modifications of cGAS-STING: A Critical Switch for Immune Regulation
Previous Article in Special Issue
Highly Efficient Genome Editing Using Geminivirus-Based CRISPR/Cas9 System in Cotton Plant
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cells
Volume 11
Issue 19
10.3390/cells11193045
cells-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Recent Progress and Future Prospect of CRISPR/Cas-Derived Transcription Activation (CRISPRa) System in Plants

by
Xiao Ding
1,2,†,
Lu Yu
2,†,
Luo Chen
2,†,
Yujie Li
2,†,
Jinlun Zhang
2,
Hanyan Sheng
2,
Zhengwei Ren
2,
Yunlong Li
2,
Xiaohan Yu
2,
Shuangxia Jin
2,* and
Jinglin Cao
3,*
1
Institute of Cotton, Shanxi Agricultural University, Yuncheng 044000, China
2
Hubei Hongshan Laboratory, National Key Laboratory of Crop Genetic Improvement, College of Plant Science and Technology, Huazhong Agricultural University, Wuhan 430070, China
3
Tobacco Research Institute of Hubei Province, Wuhan 430030, China
*
Authors to whom correspondence should be addressed.
†
These authors contribute equally to this work.
Cells 2022, 11(19), 3045; https://doi.org/10.3390/cells11193045
Submission received: 20 August 2022 / Revised: 17 September 2022 / Accepted: 23 September 2022 / Published: 28 September 2022
(This article belongs to the Special Issue Plant Genome Editing: State-of-the-Art and Perspectives in China)
Browse Figures
Review Reports Versions Notes

Abstract

:
Genome editing technology has become one of the hottest research areas in recent years. Among diverse genome editing tools, the Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated proteins system (CRISPR/Cas system) has exhibited the obvious advantages of specificity, simplicity, and flexibility over any previous genome editing system. In addition, the emergence of Cas9 mutants, such as dCas9 (dead Cas9), which lost its endonuclease activity but maintains DNA recognition activity with the guide RNA, provides powerful genetic manipulation tools. In particular, combining the dCas9 protein and transcriptional activator to achieve specific regulation of gene expression has made important contributions to biotechnology in medical research as well as agriculture. CRISPR/dCas9 activation (CRISPRa) can increase the transcription of endogenous genes. Overexpression of foreign genes by traditional transgenic technology in plant cells is the routine method to verify gene function by elevating genes transcription. One of the main limitations of the overexpression is the vector capacity constraint that makes it difficult to express multiple genes using the typical Ti plasmid vectors from Agrobacterium. The CRISPRa system can overcome these limitations of the traditional gene overexpression method and achieve multiple gene activation by simply designating several guide RNAs in one vector. This review summarizes the latest progress based on the development of CRISPRa systems, including SunTag, dCas9-VPR, dCas9-TV, scRNA, SAM, and CRISPR-Act and their applications in plants. Furthermore, limitations, challenges of current CRISPRa systems and future prospective applications are also discussed.

1. Introduction

Gene expression involves multiple processes, including transcription of DNA into messenger RNA (mRNA), splicing of mRNA, translation, and post-translation modification. Accurate regulation of DNA transcription into mRNA is the first step to control the complex process of gene expression. Directional regulation of gene expression will contribute to our understanding of cell physiology, and it is essential for advances in biotechnology.
For the regulation of endogenous gene expression, manipulating transcription factors (TFs) to target the specific target gene promoters to activate/inhibit gene transcription is the classical strategy and a successful one [1]. For example, in mammals, simultaneous up-regulation of four transcription factors reversed differential cells to pluripotent stem cells. However, it is difficult to regulate multiple genes’ transcription due to the specificity of TFs binding sites at DNA [2]. Researchers circumvented these limitations by designing a TFs binding site for promoters to regulate target genes transcription [3]. However, naturally occurring TFs have extensive DNA binding activity, which limits the specificity and efficiency of this method.
Transcription factors can only bind to fixed sites and lack flexibility. Site-specific nucleases (SSNs) such as TALEN and CRISPR/Cas9 have emerged as multipurpose tools which can greatly enhance molecular biologists’ capability such as knock out, base edit, knock in, knock up and knock down the target gene [4,5,6,7]. These SSN systems emerged as genome editing tools, and introduce DNA double-strand breaks (DSBs) anywhere in a particular genome [8,9,10]. In known DNA binding modules, inactivation of Cas9 (dead Cas9, dCas9) fused to transcriptional activators or repressor [9,11] can effectively regulate multiple genes’ transcription under the guidance of different gRNAs [12]. Overexpression of foreign genes by traditional transgenic technology in plant cells is the routine method to verify gene function and shape gene regulation. However, there are still some limitations for the wide application of this strategy. One of the main limitations is the vector capacity constraint that makes it difficult to express multiple genes using the typical Ti plasmid vectors from Agrobacterium. The cumbersome of stacking gene cloning protocol is another obstacle that limits its application. The recent advancements in CRISPR-based gene activation have offered powerful and specific induction of gene expression that overcome the limitations of traditional gene overexpression methods. Multi genes activation can be effectively realized through the CRISPRa system which provides more possibilities for the application of plant genetic improvement in the future.
In this paper, we summarized the emergence and development of transcriptional activation system based on CRISPR/dCas9 and its application in plant research. To provide a reference for plant researchers to compare the differences of different activation systems and to regulate the activation efficiency of endogenous genes in plants in the future. In addition, the potential applications, existing problems, and challenges for these new technologies were also discussed.

2. Composition of the CRISPR/Cas-Derived Activation System

2.1. CRISPR/Cas System

The CRISPR/Cas system was first investigated in 1987: scientists discovered a kind of unique DNA sequences from Escherichia coli genome, which are near the iap gene sequence and were called Clustered Regularly Interspaced Palindromic Repeats (CRISPR). However, its biological significance was unclear at that time [13]. Subsequent studies showed that CRISPR/Cas is a complex adaptive defense mechanism in prokaryotes against invading viruses or plasmid DNA [14]. Researchers found that about 40% bacteria and about 90% archaea are present in this powerful defense system [15]. Cas proteins involved in this defense mechanism have also been identified [16].
According to the repeat sequence identity of CRISPR and their Cas protein sequence homology, CRISPR/Cas system was classified into two classes and six types (as shown in Figure 1) [17,18,19]. Class I CRISPR/Cas systems require large effector protein complexes, which are classified into Type I, Type III, and Type IV. Class II CRISPR/Cas systems are classified into Type II, Type V, and Type VI, requiring only an RNA-directed endocytase to cut invading genetic components. The simplicity and efficiency of Class II system make it work as widely used genome editing tool. Type II CRISPR/Cas systems have been used in a variety of organisms, including microbes [20], fungi [21], animals [22], and plants [23].

2.2. Cas9 and dCas9

Cas9 is a specific DNA endonuclease that existed in bacteria species such as Streptococcus sepsis, Staphylococcus aureus, and Streptococcus thermophilus. It is a multifunctional protein with two ribozyme domains HNH and RuvC. First, Cas9 forms a ribosome protein complex with two small non-coding RNAs, CRISPR RNAs (crRNAs) and trans activated crRNAs (tracrRNAs). Then the RNA complex will find and identify a suitable Protospacer Adjacent Motif (PAM), such as the 5‘-NGG-3’ sequence of the target sequence [24]. Finally, Cas9 with RNA complex search and match the crRNA target sequence, and then the HNH ribozyme domain will cut the target chain, while the RuvC domain will cut the reverse chain subsequently [25,26,27].
Qi et al. (2013) mutated two conserved endonuclease domains of Cas9 in CRISPR/Cas9 system. The aspartic acid at position 10 of RuvC domain was mutated to alanine (D10A) and histidine at position 840 of HNH domain was mutated to alanine (H840A), so that Cas9 protein lost endonuclease activity and became dead Cas9 (dCas9), which cannot cut DNA but still can bind to specific target DNA sequences with the guide RNA [28]. Therefore, dCas9 binds to the upstream region of the promoter transcription start site (TSS) region and disrupts RNA polymerase or transcription factor binding to the promoter, resulting in inhibition of gene expression without altering the genome. This gene transcription regulation strategy was defined as CRISPR interference (CRISPRi) [29]. The inhibition intensity of CRISPRi system can reach 1000-fold mostly in prokaryotes [30]. CRISPR interference is also widely used in plants such as Nicotiana tabacum, Zea mays, and Arabidopsis thaliana (as shown in Table 1) [31,32,33,34,35,36]. CRISPR interference can be used as an alternative tool for RNAi. Conversely, CRISPR/Cas-derived transcriptional activation (CRISPRa) also can be achieved by dCas9. Bikard et al. (2013) fused the dCas9 protein with ω subgroups (rpoZ) in E. coli, and this dCas9-ω complex increased the reporter gene transcriptional level up to 2.8-fold [37]. The models of CRISPR mediated transcriptional regulation are shown in Figure 2.

2.3. Guide RNA (gRNA)

Guide RNA (gRNA) of CRISPR/Cas9 system is a specific RNA sequence composed of two elements: crRNA and tracrRNA. The gRNA recognizes the target DNA and directs Cas9 protein to produce double-strand breaks (DSB) in target DNA [10]. Any complementary gene or nucleotide of sgRNA sequences can be targeted by CRISPR systems. Furthermore, Cas9 and dCas9 can use multiple gRNAs effectively to expand the flexibility and multiplicity of CRISPR/Cas system by editing several different target genes simultaneously [38]. The selection of different regulatory elements and the change in regulatory efficiency can be achieved through the modification of scaffolds [39].

2.4. Transcriptional Regulators

Transcription regulatory factors are essentially chimeric proteins, and their DNA binding domains are connected with the functional domains that control the transcription mechanism by promoting the recruitment of key cofactors to regulate transcription [35]. In the CRISPR/dCas9 meditated transcription regulation system, transcriptional regulation of target genes is achieved by fusing transcription regulators with dCas9. Transcriptional Repression Domains (TRD) include transcription repressors such as the Krüppel-Associated Box (KRAB) domain. Its function is to suppress transcription by collecting co-inhibitors KRAB-Associated Protein 1 (KAP-1), which leads to the formation of heterochromatin complexes that ultimately lead to gene silencing [40]. The transcriptional repressor SRDX originate from Ethylene-responsive element binding factor-associated Amphiphilic Repression (EAR) transcriptional repressor domain, which are effective plant transcriptional repressors [41].
On the other hand, transcriptional activators such as herpes simplex Virus Protein 16 (VP16) Transcriptional Activator Domain (TAD) or tetrameric repeat VP64 [42] could elevate the target genes’ transcription. Plant also has its own specific transcription regulators such as Ethylene Responsive Factor/Ethylene-Responsive Element Binding Proteins (ERF/EREBP). They can maintain high activity even in the presence of activating elements (such as VP16). This domain has been used as a tool for transcriptional inhibition in some studies [40]. Ethylene response factors in the ERF/EREBP family play a leading role in the response to biological and abiotic stress [43]. These transcriptional regulators bind to the APETALA2(AP2) DNA domain and various unnamed motifs [44,45,46]. These sequences are EDLL short sequences consisting of conserved glutamate (E), aspartic acid (D), and leucine (L). Several studies showed that the EDLL motif is a powerful tool for endogenous gene transcriptional activation [47,48]. Transcriptional activation domains and their detail description are summarized in Table 2.

3. Strategies for Achieving Transcriptional Activation using the CRISPR/dCas9 System

As mentioned previously, transcriptional activators are essential for the regulation of transcriptional activation through dCas9. Regulation of target gene activation can be achieved by fusing transcriptional activators with dCas9, or by directing gRNA into scaffolds to recruit transcriptional activators. A comparison of different activation systems using these two strategies and evaluating their efficiency is summarized below:

3.1. Fusion of Transcriptional Activation Effectors with dCas9

Studies showed that the dCas9 protein fused with the transcription factor VP64 can recruit and stabilize the promoter complex to form dCas9-VP64 [49]. However, dCas9-VP64 is a low-intensity activator with less than 10-fold target gene transcription [32,34,36]. Although higher levels of expression may be desirable to observe more pronounced phenotypes associated with the function of certain genes, these results clearly show that Cas9-based transcription factors can activate endogenous gene expression [50]. Based on this, the researchers attempted to string other different activators together with dCas9 and this resulted in the following three systems:

3.1.1. dCas9- SunTag System

Researchers found that the combination of multiple transcription factors with a single promoter significantly enhanced transcriptional activation of the downstream gene. This principle of signal amplification through protein polymers had been applied in biological system imaging and engineering design [51]. Based on this principle, Tanenbaum et al. (2014) developed a novel protein scaffold, a repeating peptide array called SunTag for transcription activation [52].
In the Super Nova Tag (SunTag) system, dCas9 is fused with tandem General Control Nonderepressible 4(GCN4) peptide repeats and each repeat connects a transcription regulator via an anti-GCN4 antibody called Single Chain Fragment Variable (scFv). The domain has highly affinity with relatively short nucleic acid sequences, allowing for protein polymerization on a single RNA template. Compared to the dCas9-VP64, SunTag enables multiple transcription factors such as Ten-Eleven Translocation (TET) and regulatory elements X to be recruited in one system. Therefore, multiple genes can be synergistically activated by different transcriptional regulators in tandem [53] as shown in Figure 3A.

3.1.2. dCas9-VPR System

In natural gene regulation system in cells, many transcription factor Activation Domains (ADs) can make changes in transcription through a coordinated collection of necessary activators. Chavez et al. (2015) hypothesized that transcriptional activation could be enhanced by combining multiple Ads [54]. A series of more than 20 known transcriptional effectors were fused to the C-terminus of dCas9 in an effort to enhance the transcriptional activation efficiency in human HEK 293T cells. The result show that dCas9-VP64, dCas9-p65 [55] and dCas9-Rta [56] were active. Then researchers used Cas9-VP64 as their starting scaffold and expanded up-regulation with p65 and Rta at the C-terminal, resulting in VP64-p65-Rta (VPR) activator complex as shown in Figure 3B. This novel activator displayed increased transcription levels of endogenous target gene, ranging from 20-fold to 320-fold over the original dCas9-VP64 activator [54].

3.1.3. dCas9-TV System

Currently, the CRISPRa system is continually being optimized and improved in animal cells, whereas it is still at an early stage for plant cells. The dCas9-TV system is the first CRISPR/dCas9 activation system applied in plant cells [57].
Li et al. (2017) modified dCas9-VP64 with VP16’s octahedron VP128 instead of VP64 and this system activated LUC with a five-fold increase; an improved performance on the dCas9-VP64 (only a two-fold increase). TAD was then introduced as a second step to enhance dCas9-VP128 activity, including plant-specific EDLL and modified ERF2 (ERF2m) and TAD from the herpes simplex virus’ TALE element. Results showed that the combination of VP128 with a tandem ERF2m-EDLL motif (up to four copies) activated LUC transcription up to 12.6-fold compared to the base level, while combination of VP128 and TALE TAD (up to six copies) increased LUC transcription up to 55-fold. The results suggested that dCas9-6TAL-VP128 was a strong transcriptional activator and was called the dCas9-TV system [39,57] as shown in Figure 3C.

3.2. Modification of gRNA into a Scaffold and Recruitment of Transcriptional Activators

A common method for studying RNA localization is to insert multiple MS2-binding RNA scaffolds into the target RNA molecule and then tag the RNA molecule with GFP by recruiting MS2-GFP fusion proteins [51]. The inherently modular and programmable nature of RNA allows it to be used to coordinate biological assembly. First of all, RNA can recognize DNA targets via the complementary base pairing principle. Second, RNA contains a domain of RNA-protein interactions that are useful for recruiting specific proteins. Previous studies demonstrated that RNA scaffolds can coordinate the assembly of functional proteins [58]. Therefore, a second common strategy for CRISPR/dCas9 derived transcriptional activation system is to use gRNA as scaffold to recruit transcriptional activators.

3.2.1. scRNA System

Zalatan et al. (2015) constructed a scaffold RNA (scRNA) system and demonstrated that it can effectively activate gene transcription in yeast and human cells [29]. ScRNA systems are inspired by natural regulatory systems in which scaffold proteins physically assemble interacting components of cell signaling pathways. Similar scaffolding principles were applied in genomic modification, such as using Long-strand Non-Coding RNA (lncRNA) as assembly scaffolds to recruit key epigenetic modifiers at specific genomic sites [59,60]. In this system, the researchers fused the well-characterized viral RNA sequences including MS2, PP7, and Com into the 3′-end of gRNA, which are recognized by RNA binding proteins, respectively. Then, the transcriptional activation domain VP64 was fused to each corresponding RNA binding proteins, as shown in Figure 3D.

3.2.2. SAM System

Synergistic Activation Mediator (SAM) continues to be constructed by modifying gRNA loops. Initially, the researchers tried to find the best anchoring position for the activation domain in the Cas9-sgRNA complex. Previously, dCas9-based transcription activators relied on trans activation domains fused to the N or C ends of dCas9 proteins. For an investigation regarding alternative anchorage sites, Konermann et al. (2015) investigated the crystal structure of dCas9 and revealed that the distal gRNA loops did not interact with dCas9 at all. Other research revealed that the gRNA loops could fuse with protein-interacting RNA domains to promote transcription factor recruitment to dCas9 [61]. They combined VP64 with the NF-κB activation p65 [62] and reintroduced the activation domain of Human Heat Shock Transcription Factor 1 (HSF1) for improving the efficiency of dCas9-mediated gene activation (Figure 3E). Finalization of MS2-p65-HSF1 fusion protein improved ASCL1 (12%) and MYOD1 (37%) transcription activation [61]. Some results demonstrated that the SAM gene activation platform can facilitate in vivo research and drug discovery [63].

3.2.3. CRISPR-Act 2.0 System

The CRISPR-Act 2.0 system is an improved system for multiple transcriptional activation in plants, which is also dependent on MS2. It is capable of recruiting four VP64 proteins to gRNA and the fifth VP64 was carried by the dCas9-VP64 complex. As shown in Figure 3F, this system can carry a total of five activators to the target site. When compared to the original dCas9-VP64 system, CRISPR-Act 2.0 increased transcriptional activation efficiency by three to four folds [64]. Additionally, the CRISPR-Act 2.0 system enables simultaneous activation of multiple genes in vivo. Lowder et al. (2017) assessed the efficacy of the CRISPR-Act 2.0 system in rice. They simultaneously activated three independent endogenous genes Os11g35410, Os03g01240 and Os04g39780 in rice protoplasm [48,64]. The results indicated that CRISPR-Act 2.0 was more effective than the previous dCas9-VP64 systems.

3.2.4. CRISPR-Act3.0 System

Based on the CRISPR-Act 2.0 system, Pan et al. (2021) combined dCas9-VP64, gR 2.0 scaffolds, 10xGCN4 SunTag and a newly developed 2xTAD activator to build a novel CRISPR-activating system, CRISPR-Act3.0 [65], as shown in Figure 3G. Multigene activation was achieved by assembling gRNA with multiple activators. At the same time, the further combination with CRISPR-Cas12b and the SpCas9 variant SPRY may expand the target range of CRISPR-activation. The primary objective of functional genomics is to determine the causal relationship between gene expression and phenotypic characteristics. By regulating gene expression in plants, the CRISPRa system provides a novel, efficient method to simplify and accelerate these studies. The future holds a lot of potential for improving CRISPR-activation efficiency, flexibility, and scalability.

4. Application and Limitation of CRISPRa System in Plants

First, the researchers used A. thaliana and N. benthamiana for transcription activation test to evaluate the transcriptional activation activity of dcas9-VP64. The data suggested that dCas9-VP64 had weak activation when a single sgRNA was designed in the vector. Then, the adoption of multiple sgRNAs to target the same gene promoter resulted in higher level of gene activation [32,35,47,66]. Transcription activation domains from plant AP2 transcription factors as known as the EDLL motif and bacterial TALE protein have been used to construct dCas9-based transcriptional activators in plants [64,66]. Li et al. (2017) designed a transcriptional activation system dCas9-TV that works effectively in plants. High-level transcriptional activation of target genes in A. thaliana and O. sativa and rice cells was achieved with a 201-fold and 2745-fold increase, respectively [57]. Xiong et al. (2021) further optimized dCas9-TV system in rice to increase the transcription of OSER1 gene up to 4000-fold [67]. Researchers also tried to link the EDLL motif with VP64, in a similar fashion to the VPR strategy, in order to increase the efficiency of transcriptional activation in rice [68]. Selma et al. (2022) used multipliable CRISPR activator dCasEV2.1 activated 3 and 7 genes with gene activation levels ranging from 4- to 1500-fold in N. benthamiana [69].
Similarly, transcriptional activation of endogenous target genes was also efficiently applied in A. thaliana when SAM or SunTag were fused with the dCas9 [70,71]. When using the same gRNA, the CRISPR-Act2.0 system significantly outperformed the dCas9-VP64 system to activate target genes in A. thaliana cells with a 1500-fold increase [64]. CRISPR-Act3.0 recruits additional activators based on the SunTag system coupled to MS2-MCP which increased activation efficiency of endogenous genes in rice (250-fold), Arabidopsis (4000-fold) and tomato (240-fold), respectively [65]. It is important to note that even with effective activation systems, such as CRISPR-Act 2.0 and dCas9-TV, some endogenous genes are also difficult to activate effectively [64,66]. It is speculated that dCas9 and activators must compete with endogenous transcription activators to bind the specific region of promoters. The activation system and activation efficiency applied in plant species are summarized in Table 2.
The current CRISPR/dCas9-based transcription system needs to be delivered in plant by Agrobacterium, Polyethylene Glycol (PEG) or particle bombardment techniques. The donor plants should harbor the T-DNA insertion with CRISPR/dCas9 fragment may be regulated under the biosafety framework for GM plants since they contain transgene element in the genome. This is maybe the major concern for wide application of the current CRISPR/dCas9 mediated transcription activation system in plant. In addition, with the miniaturization of Cas protein and the maturity of virus introduction technology, it will leave the tissue culture stage and accelerate the efficiency of related research. It is anticipated that transcriptional regulation using CRISPR will be further improved by overcoming the technical difficulties mentioned above in the near future.

5. Concluding Remarks and Perspective of Transcription Activation System in Plants

This paper reviews the different strategies developed based on CRISPR/dcas9 activation system in recent years. These strategies have been widely employed to study gene transcription regulation in animal cells; however, their application in plants is still at its early stages. In plants, this system is mainly used in the model plant species such as Arabidopsis and rice, but not in other major crop plant species. Nevertheless, there is still a great deal of potential for research in this field. First, the multi gene activation system enables large-scale transcriptional regulation in plants in order to better understand gene regulatory networks. Second, the up-regulation of multiple key genes in the metabolic pathway can generally result in the production of valuable commercial products, and synthetic biology is likely to make a significant breakthrough in the field of agriculture [72]. Additionally, the improvement of the protein complexes function is mainly dependent upon the simultaneous activation of many different genes, and the multigene activation system is helpful for studying the functional region of complex proteins [73]. Finally, directed activation of multiple defense genes against pathogen attack is a potential strategy to improve plant immunity without affecting traits [74]. Plants are able to recognize insect molecules and respond accurately and defensively when insects are grazing. However, the effectors released by insects interfere with the host plant’s defensive response. We can use the CRISPR-activation system to avoid the destruction of plant defense mechanisms by insect effectors and create broad-spectrum insect-resistant plant materials. Several novel gene editing tools such as Cas12a T-containing PAM with short guide RNA (42–44 nucleotides of crRNA), appeared to be more effective in regulating multiple genes [75].
Ongoing efforts are being made to update the transcriptional activation system based on CRISPR/dCas9. For example, Chiarella et al. (2020) improved CRISPR/dCas9-based transcriptional activation using Chemogenetic Epigenetic Modifiers (CEMs). By employing endogenous chromatin activators, this system was able to activate target gene expression without requiring exogenous transcriptional activators, leading to dose-dependent activations of target genes [76]. Gamboa et al. (2020) integrates the heat shock switch with dCas9 complex to remotely control gene activation and inhibition with short-time heating pulses [77]. The experimental results demonstrated that the activation intensity of the dCas9-VP64 complex with heat as remote trigger depends on thermal pulse and can be substantially improved in only 15 min. With this heat-activated transcriptional activation system, CRISPR/dCas9 can activate transcription without invasive procedures. Optical regulation can be used as another new method for inducing and regulating endogenous genes in plants. Moreover, in an attempt to overcome the problems associated with the compatibility of optogenetic tools with plant growth requirements, Ochoa-Fernandez et al. (2020) developed Plant-Usable Light-Switch Elements (PULSE). A combination of blue light sensing inhibition regulation with red light sensing activation regulation resulted in gene expression being regulated only in the presence of red light. Combining PULSE with CRISPR/dCas9 mediated gene activation system (dCas9-TV) demonstrated light controlled activation of A. thaliana [78].
As opposed to ribozymes with cutting activity, which often cause uncertain genomic modifications and result in chromosome rearrangements or deletion during multiple point editing, dCas ribozymes offer a superior solution to these problems [79]. However, the challenge remains in creating long sequences of multiple gRNAs strung together and determining their editing efficiency for various targets [80]. Under a multilocus CRISPR editing system, the increased number of gRNAs leads to limited dcas9 competition between different gRNAs, which in turn leads to variations in target gene editing efficiency [81], as well as uncertainty in the regulation of target genes by gRNAs [82]. As mentioned previously, CRISPR/dCas9 derived transcription activation system exhibited obvious advantages over the traditional overexpression strategy to elevate the target genes’ transcription.
Epigenetic regulation is an important way to regulate gene expression and has certain reversibility. The researchers used CRISPR/Cas9 to knock out epigenetic factors to determine the role of epigenetic factors in the regulation of endogenous genes in plants [83]. In addition, researchers can combine CRISPR/dCas with different epigenetic effector domains for specific epigenetic regulation of target sites [84]. In the future, with the improvement of episequencing technology and the in-depth study of epigenetic regulators, CRISPR-based epigenetic regulation research will have room for development.
Finally, with the wide application of single-cell sequencing technology in plants [85], it will further improve the transcriptional regulation information of plants [86] and open up new space for the application of CRISPR-activation system in plants.

Author Contributions

Conceptualization, S.J. and X.D.; formal analysis, L.Y. and Y.L. (Yujie Li); creation of models, L.C.; data curation, J.Z.; writing—original draft preparation, H.S., Z.R., Y.L. (Yunlong Li) and X.Y.; writing—review and editing, S.J. and J.C.; funding acquisition, J.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Research Project on Agricultural Science and Technology Innovation of Shanxi Academy of Agricultural Sciences (grant number GJPY2010) and Research fundings (grant number 2021hszd013, 027Y2018-007) to Jinglin Cao and Shuangxia Jin.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Spitz, F.; Furlong, E.E.M. Transcription Factors: From Enhancer Binding to Developmental Control. Nat. Rev. Genet. 2012, 13, 613–626. [Google Scholar] [CrossRef] [PubMed]
  2. Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448, 313–317. [Google Scholar] [CrossRef] [PubMed]
  3. Kumar, S.; Alabed, D.; Whitteck, J.T.; Chen, W.; Bennett, S.; Asberry, A.; Wang, X.; Desloover, D.; Rangasamy, M.; Wright, T.R.; et al. A combinatorial bidirectional and bicistronic approach for coordinated multi-gene expression in corn. Plant Mol. Biol. 2015, 87, 341–353. [Google Scholar] [CrossRef] [PubMed]
  4. Weeks, D.P.; Spalding, M.H.; Yang, B. Use of designer nucleases for targeted gene and genome editing in plants. Plant Biotechnol. J. 2016, 14, 483–495. [Google Scholar] [CrossRef]
  5. Wang, Q.; Alariqi, M.; Wang, F.; Li, B.; Ding, X.; Rui, H.; Li, Y.; Xu, Z.; Qin, L.; Sun, L.; et al. The application of a heat-inducible CRISPR/Cas12b (C2c1) genome editing system in tetraploid cotton (G. hirsutum) plants. Plant Biotechnol. J. 2020, 18, 2436–2443. [Google Scholar] [CrossRef]
  6. Zhang, D.; Hussain, A.; Manghwar, H.; Xie, K.; Xie, S.; Zhao, S.; Larkin, R.M.; Qing, P.; Jin, S.; Ding, F. Genome editing with the CRISPR-Cas system: An art, ethics and global regulatory perspective. Plant Biotechnol. J. 2020, 18, 1651–1669. [Google Scholar] [CrossRef]
  7. Wang, G.; Xu, Z.; Wang, F.; Huang, Y.; Xin, Y.; Liang, S.; Li, B.; Si, H.; Sun, L.; Wang, Q.; et al. Development of an efficient and precise adenine base editor (ABE) with expanded target range in allotetraploid cotton (Gossypium hirsutum). BMC Biol. 2022, 20, 45. [Google Scholar] [CrossRef]
  8. Ran, F.A.; Hsu, P.D.; Lin, C.Y.; Gootenberg, J.S.; Konermann, S.; Trevino, A.E.; Scott, D.A.; Inoue, A.; Matoba, S.; Zhang, Y.; et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell. 2013, 154, 1380–1389. [Google Scholar] [CrossRef]
  9. Cong, L.; Ran, F.A.; Cox, D.; Lin, S.; Barretto, R.; Habib, N.; Hsu, P.D.; Wu, X.; Jiang, W.; Marraffini, L.A.; et al. Multiplex Genome Engineering Using CRISPR/Cas Systems. Science 2013, 339, 819–823. [Google Scholar] [CrossRef]
  10. Zhang, H.; Zhang, J.; Wei, P.; Zhang, B.; Gou, F.; Feng, Z.; Mao, Y.; Yang, L.; Zhang, H.; Xu, N.; et al. The CRISPR/Cas9 system produces specific and homozygous targeted gene editing in rice in one generation. Plant Biotechnol. J. 2014, 12, 797–807. [Google Scholar] [CrossRef]
  11. Lowder, L.; Malzahn, A.; Qi, Y. Rapid Evolution of Manifold CRISPR Systems for Plant Genome Editing. Front. Plant Sci. 2016, 7, 1683. [Google Scholar] [CrossRef] [PubMed]
  12. Moradpour, M.; Abdulah, S.N.A. CRISPR/dCas9 platforms in plants: Strategies and applications beyond genome editing. Plant Biotechnol. J. 2020, 18, 32–44. [Google Scholar] [CrossRef] [PubMed]
  13. Ishino, Y.; Shinagawa, H.; Makino, K.; Amemura, M.; Nakata, A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J. Bacteriol. 1987, 169, 5429–5433. [Google Scholar] [CrossRef] [PubMed]
  14. Barrangou, R.; Fremaux, C.; Deveau, H.; Richards, M.; Boyaval, P.; Moineau, S.; Romero, D.A.; Horvath, P. CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes. Science 2007, 315, 1709–1712. [Google Scholar] [CrossRef]
  15. Grissa, I.; Vergnaud, G.; Pourcel, C. CRISPRFinder: A web tool to identify clustered regularly interspaced short palindromic repeats. Nucleic Acids Res. 2007, 35, W52–W57. [Google Scholar] [CrossRef]
  16. Jinek, M.; Chylinski, K.; Fonfara, I.; Hauer, M.; Doudna, J.A.; Charpentier, E. A Programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012, 337, 816–821. [Google Scholar] [CrossRef] [PubMed]
  17. Makarova, K.S.; Zhang, F.; Koonin, E.V. SnapShot: Class 1 CRISPR-Cas Systems. Cell 2017, 168, 946.e1. [Google Scholar] [CrossRef]
  18. Manghwar, H.; Lindsey, K.; Zhang, X.; Jin, S. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing. Trends Plant Sci. 2019, 24, 1102–1125. [Google Scholar] [CrossRef]
  19. Li, B.; Rui, H.; Li, Y.; Wang, Q.; Alariqi, M.; Qin, L.; Sun, L.; Ding, X.; Wang, F.; Zou, J.; et al. Robust CRISPR/Cpf1 (Cas12a)-mediated genome editing in allotetraploid cotton (Gossypium hirsutum). Plant Biotechnol. J. 2019, 17, 1862–1864. [Google Scholar] [CrossRef]
  20. Cobb, R.E.; Wang, Y.; Zhao, H. High-Efficiency Multiplex Genome Editing of Streptomyces Species Using an Engineered CRISPR/Cas System. ACS Synth. Biol. 2015, 4, 723–728. [Google Scholar] [CrossRef] [Green Version]
  21. Apel, A.R.; D’Espaux, L.; Wehrs, M.; Sachs, D.; Li, R.A.; Tong, G.J.; Garber, M.; Nnadi, O.; Zhuang, W.; Hillson, N.J.; et al. A Cas9-based toolkit to program gene expression in Saccharomyces cerevisiae. Nucleic Acids Res. 2017, 45, 496–508. [Google Scholar] [CrossRef]
  22. Hwang, W.Y.; Fu, Y.; Reyon, D.; Maeder, M.L.; Tsai, S.Q.; Sander, J.D.; Peterson, R.T.; Yeh, J.-R.J.; Joung, J.K. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 2013, 31, 227–229. [Google Scholar] [CrossRef] [PubMed]
  23. Xie, K.; Yang, Y. RNA-Guided Genome Editing in Plants Using a CRISPR–Cas System. Mol. Plant 2013, 6, 1975–1983. [Google Scholar] [CrossRef] [PubMed]
  24. Chylinski, K.; Le Rhun, A.; Charpentier, E. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol. 2013, 10, 726–737. [Google Scholar] [CrossRef]
  25. Nishimasu, H.; Cong, L.; Yan, W.X.; Ran, F.A.; Zetsche, B.; Li, Y.; Kurabayashi, A.; Ishitani, R.; Zhang, F.; Nureki, O. Crystal Structure of Staphylococcus aureus Cas9. Cell 2015, 162, 1113–1126. [Google Scholar] [CrossRef]
  26. Jinek, M.; Jiang, F.; Taylor, D.W.; Sternberg, S.H.; Kaya, E.; Ma, E.; Anders, C.; Hauer, M.; Zhou, K.; Lin, S.; et al. Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation. Science 2014, 343, 1247997. [Google Scholar] [CrossRef]
  27. Anders, C.; Niewoehner, O.; Duerst, A.; Jinek, M. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 2014, 513, 569–573. [Google Scholar] [CrossRef]
  28. Qi, L.S.; Larson, M.H.; Gilbert, L.A.; Doudna, J.A.; Weissman, J.S.; Arkin, A.P.; Lim, W.A. Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression. Cell 2013, 152, 1173–1183. [Google Scholar] [CrossRef]
  29. Zalatan, J.; Lee, M.E.; Almeida, R.; Gilbert, L.; Whitehead, E.H.; La Russa, M.; Tsai, J.; Weissman, J.S.; Dueber, J.E.; Qi, L.S.; et al. Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA Scaffolds. Cell 2015, 160, 339–350. [Google Scholar] [CrossRef]
  30. Wang, Y.; Zhang, Z.-T.; Seo, S.-O.; Lynn, P.; Lu, T.; Jin, Y.-S.; Blaschek, H.P. Gene transcription repression in Clostridium beijerinckii using CRISPR-dCas9. Biotechnol. Bioeng. 2016, 113, 2739–2743. [Google Scholar] [CrossRef]
  31. Tang, X.; Lowder, L.G.; Zhang, T.; Malzahn, A.A.; Zheng, X.; Voytas, D.F.; Zhong, Z.; Chen, Y.; Ren, Q.; Li, Q.; et al. Correction: A CRISPR–Cpf1 system for efficient genome editing and transcriptional repression in plants. Nat. Plants 2017, 3, 17103. [Google Scholar] [CrossRef] [PubMed]
  32. Vazquez-Vilar, M.; Bernabé-Orts, J.M.; Fernandez-Del-Carmen, A.; Ziarsolo, P.; Blanca, J.; Granell, A.; Orzaez, D. A modular toolbox for gRNA–Cas9 genome engineering in plants based on the GoldenBraid standard. Plant Methods 2016, 12, 10. [Google Scholar] [CrossRef] [PubMed]
  33. Han, L.; Haslam, R.P.; Silvestre, S.; Lu, C.; Napier, J.A. Enhancing the accumulation of eicosapentaenoic acid and docosahexaenoic acid in transgenic Camelina through the CRISPR-Cas9 inactivation of the competing FAE1 pathway. Plant Biotechnol. J. 2022, 20, 1444–1446. [Google Scholar] [CrossRef] [PubMed]
  34. Gentzel, I.N.; Park, C.H.; Bellizzi, M.; Xiao, G.; Gadhave, K.R.; Murphree, C.; Yang, Q.; LaMantia, J.; Redinbaugh, M.G.; Balint-Kurti, P.; et al. A CRISPR/dCas9 toolkit for functional analysis of maize genes. Plant Methods 2020, 16, 133. [Google Scholar] [CrossRef]
  35. Piatek, A.; Ali, Z.; Baazim, H.; Li, L.; Abulfaraj, A.; Al-Shareef, S.; Aouida, M.; Mahfouz, M.M. RNA-guided transcriptional regulation in planta via synthetic dCas9-based transcription factors. Plant Biotechnol. J. 2015, 13, 578–589. [Google Scholar] [CrossRef]
  36. Lowder, L.G.; Zhang, D.; Baltes, N.J.; Paul, J.W.; Tang, X.; Zheng, X.; Voytas, D.F.; Hsieh, T.-F.; Zhang, Y.; Qi, Y. A CRISPR/Cas9 Toolbox for Multiplexed Plant Genome Editing and Transcriptional Regulation. Plant Physiol. 2015, 169, 971–985. [Google Scholar] [CrossRef]
  37. Bikard, D.; Jiang, W.; Samai, P.; Hochschild, A.; Zhang, F.; Marraffini, L.A. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res. 2013, 41, 7429–7437. [Google Scholar] [CrossRef]
  38. Didovyk, A.; Borek, B.; Tsimring, L.; Hasty, J. Transcriptional regulation with CRISPR-Cas9: Principles, advances, and applications. Curr. Opin. Biotechnol. 2016, 40, 177–184. [Google Scholar] [CrossRef]
  39. Li, Z.; Xiong, X.; Li, J.-F. The working dead: Repurposing inactive CRISPR-associated nucleases as programmable transcriptional regulators in plants. aBIOTECH 2020, 1, 32–40. [Google Scholar] [CrossRef]
  40. Collins, T.; Stone, J.R.; Williams, A.J. All in the Family: The BTB/POZ, KRAB, and SCAN Domains. Mol. Cell. Biol. 2001, 21, 3609–3615. [Google Scholar] [CrossRef] [Green Version]
  41. Hiratsu, K.; Matsui, K.; Koyama, T.; Ohme-Takagi, M. Dominant repression of target genes by chimeric repressors that include the EAR motif, a repression domain, in Arabidopsis. Plant J. 2003, 34, 733–739. [Google Scholar] [CrossRef] [PubMed]
  42. Perez-Pinera, P.; Ousterout, D.G.; Brunger, J.M.; Farin, A.M.; Glass, K.A.; Guilak, F.; Crawford, G.E.; Hartemink, A.J.; Gersbach, C.A. Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat. Methods 2013, 10, 239–242. [Google Scholar] [CrossRef] [PubMed]
  43. Tiwari, S.B.; Belachew, A.; Ma, S.F.; Young, M.; Ade, J.; Shen, Y.; Marion, C.M.; Holtan, H.E.; Bailey, A.; Stone, J.K.; et al. The EDLL motif: A potent plant transcriptional activation domain from AP2/ERF transcription factors. Plant J. 2012, 70, 855–865. [Google Scholar] [CrossRef] [PubMed]
  44. Azzeme, A.M.; Abdullah, S.N.A.; Aziz, M.A.; Wahab, P.E.M. Oil palm drought inducible DREB1 induced expression of DRE/CRT- and non-DRE/CRT-containing genes in lowland transgenic tomato under cold and PEG treatments. Plant Physiol. Biochem. 2017, 112, 129–151. [Google Scholar] [CrossRef] [PubMed]
  45. Abdullah, S.N.A.; Ho, C.-L.; Carol, W. Crop Improvement; Springer: Berlin/Heidelberg, Germany, 2017; pp. 71–99. [Google Scholar]
  46. Ebrahimi, M.; Abdullah, S.N.A.; Aziz, M.A.; Namasivayam, P. Oil palm EgCBF3 conferred stress tolerance in transgenic tomato plants through modulation of the ethylene signaling pathway. J. Plant Physiol. 2016, 202, 107–120. [Google Scholar] [CrossRef] [PubMed]
  47. Çevik, V.; Kidd, B.N.; Zhang, P.; Hill, C.; Kiddle, S.; Denby, K.; Holub, E.B.; Cahill, D.; Manners, J.M.; Schenk, P.; et al. MEDIATOR25 Acts as an Integrative Hub for the Regulation of Jasmonate-Responsive Gene Expression in Arabidopsis. Plant Physiol. 2012, 160, 541–555. [Google Scholar] [CrossRef] [PubMed]
  48. Lowder, L.G.; Paul, J.W.; Qi, Y. Plant Gene Regulatory Networks; Springer: Berlin/Heidelberg, Germany, 2017; pp. 167–184. [Google Scholar]
  49. Perez-Pinera, P.; Kocak, D.D.; Vockley, C.M.; Adler, A.F.; Kabadi, A.M.; Polstein, L.R.; Thakore, P.I.; Glass, K.A.; Ousterout, D.G.; Leong, K.W.; et al. RNA-guided gene activation by CRISPR-Cas9–based transcription factors. Nat. Methods 2013, 10, 973–976. [Google Scholar] [CrossRef] [PubMed]
  50. Paul, J.W.; Qi, Y. CRISPR/Cas9 for plant genome editing: Accomplishments, problems and prospects. Plant Cell Rep. 2016, 35, 1417–1427. [Google Scholar] [CrossRef] [PubMed]
  51. Fusco, D.; Accornero, N.; Lavoie, B.; Shenoy, S.M.; Blanchard, J.-M.; Singer, R.H.; Bertrand, E. Single mRNA Molecules Demonstrate Probabilistic Movement in Living Mammalian Cells. Curr. Biol. 2003, 13, 161–167. [Google Scholar] [CrossRef]
  52. Tanenbaum, M.E.; Gilbert, L.A.; Qi, L.S.; Weissman, J.S.; Vale, R.D. A Protein-Tagging System for Signal Amplification in Gene Expression and Fluorescence Imaging. Cell 2013, 159, 635–646. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Morita, S.; Horii, T.; Kimura, M.; Hatada, I. Synergistic Upregulation of Target Genes by TET1 and VP64 in the dCas9–SunTag Platform. Int. J. Mol. Sci. 2020, 21, 1574. [Google Scholar] [CrossRef] [PubMed]
  54. Chavez, A.; Scheiman, J.; Vora, S.; Pruitt, B.W.; Tuttle, M.; Iyer, E.P.R.; Lin, S.; Kiani, S.; Guzman, C.D.; Wiegand, D.J.; et al. Highly efficient Cas9-mediated transcriptional programming. Nat. Methods 2015, 12, 326–328. [Google Scholar] [CrossRef] [PubMed]
  55. Van Essen, D.; Engist, B.; Natoli, G.; Saccani, S. Two Modes of Transcriptional Activation at Native Promoters by NF-κB p65. PLoS Biol. 2009, 7, e1000073. [Google Scholar] [CrossRef] [PubMed]
  56. Gwack, Y.; Baek, H.J.; Nakamura, H.; Lee, S.H.; Meisterernst, M.; Roeder, R.G.; Jung, J.U. Principal Role of TRAP/Mediator and SWI/SNF Complexes in Kaposi's Sarcoma-Associated Herpesvirus RTA-Mediated Lytic Reactivation. Mol. Cell. Biol. 2003, 23, 2055–2067. [Google Scholar] [CrossRef]
  57. Li, Z.; Zhang, D.; Xiong, X.; Yan, B.; Xie, W.; Sheen, J.; Li, J.-F. A potent Cas9-derived gene activator for plant and mammalian cells. Nat. Plants 2017, 3, 930–936. [Google Scholar] [CrossRef]
  58. Delebecque, C.J.; Lindner, A.B.; Silver, P.A.; Aldaye, F.A. Organization of Intracellular Reactions with Rationally Designed RNA Assemblies. Science 2011, 333, 470–474. [Google Scholar] [CrossRef]
  59. Spitale, R.C.; Tsai, M.-C.; Chang, H.Y. RNA templating the epigenome. Epigenetics 2011, 6, 539–543. [Google Scholar] [CrossRef]
  60. Rinn, J.L.; Chang, H.Y. Genome Regulation by Long Noncoding RNAs. Annu. Rev. Biochem. 2012, 81, 145–166. [Google Scholar] [CrossRef]
  61. Konermann, S.; Brigham, M.; Trevino, A.E.; Joung, J.; Abudayyeh, O.O.; Barcena, C.; Hsu, P.; Habib, N.; Gootenberg, J.; Nishimasu, H.; et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 2015, 517, 583–588. [Google Scholar] [CrossRef]
  62. Lemon, B.; Tjian, R. Orchestrated response: A symphony of transcription factors for gene control. Genes Dev. 2000, 14, 2551–2569. [Google Scholar] [CrossRef] [Green Version]
  63. Hunt, C.; Hartford, S.A.; White, D.; Pefanis, E.; Hanna, T.; Herman, C.; Wiley, J.; Brown, H.; Su, Q.; Xin, Y.; et al. Tissue-specific activation of gene expression by the Synergistic Activation Mediator (SAM) CRISPRa system in mice. Nat. Commun. 2021, 12, 2770. [Google Scholar] [CrossRef] [PubMed]
  64. Lowder, L.G.; Zhou, J.; Zhang, Y.; Malzahn, A.; Zhong, Z.; Hsieh, T.-F.; Voytas, D.F.; Zhang, Y.; Qi, Y. Robust Transcriptional Activation in Plants Using Multiplexed CRISPR-Act2.0 and mTALE-Act Systems. Mol. Plant 2018, 11, 245–256. [Google Scholar] [CrossRef] [PubMed]
  65. Pan, C.; Wu, X.; Markel, K.; Malzahn, A.A.; Kundagrami, N.; Sretenovic, S.; Zhang, Y.; Cheng, Y.; Shih, P.M.; Qi, Y. CRISPR–Act3.0 for highly efficient multiplexed gene activation in plants. Nat. Plants 2021, 7, 942–953. [Google Scholar] [CrossRef] [PubMed]
  66. Ren, C.; Li, H.; Liu, Y.; Li, S.; Liang, Z. Highly efficient activation of endogenous gene in grape using CRISPR/dCas9-based transcriptional activators. Hortic. Res. 2022, 9, uhab037. [Google Scholar] [CrossRef]
  67. Xiong, X.; Liang, J.; Li, Z.; Gong, B.; Li, J. Multiplex and optimization of dCas9-TV-mediated gene activation in plants. J. Integr. Plant Biol. 2021, 63, 634–645. [Google Scholar] [CrossRef]
  68. Lee, D.; Hua, L.; Khoshravesh, R.; Giuliani, R.; Kumar, I.; Cousins, A.; Sage, T.L.; Hibberd, J.M.; Brutnell, T.P. Engineering chloroplast development in rice through cell-specific control of endogenous genetic circuits. Plant Biotechnol. J. 2021, 19, 2291–2303. [Google Scholar] [CrossRef]
  69. Selma, S.; Sanmartín, N.; Espinosa-Ruiz, A.; Gianoglio, S.; Lopez-Gresa, M.P.; Vázquez-Vilar, M.; Flors, V.; Granell, A.; Orzaez, D. Custom-made design of metabolite composition in N. benthamiana leaves using CRISPR activators. Plant Biotechnol. J. 2022, 20, 1578–1590. [Google Scholar] [CrossRef]
  70. Park, J.; Dempewolf, E.; Zhang, W.; Wang, Z.-Y. RNA-guided transcriptional activation via CRISPR/dCas9 mimics overexpression phenotypes in Arabidopsis. PLoS ONE 2017, 12, e0179410. [Google Scholar] [CrossRef]
  71. Papikian, A.; Liu, W.; Gallego-Bartolomé, J.; Jacobsen, S.E. Site-specific manipulation of Arabidopsis loci using CRISPR-Cas9 SunTag systems. Nat. Commun. 2019, 10, 729. [Google Scholar] [CrossRef]
  72. Zorrilla-López, U.; Masip, G.; Arjó, G.; Bai, C.; Banakar, R.; Bassie, L.; Berman, J.; Farré, G.; Miralpeix, B.; Pérez-Massot, E.; et al. Engineering metabolic pathways in plants by multigene transformation. Int. J. Dev. Biol. 2013, 57, 565–576. [Google Scholar] [CrossRef] [Green Version]
  73. Dzivenu, O.K.; Park, H.H.; Wu, H. General co-expression vectors for the overexpression of heterodimeric protein complexes in Escherichia coli. Protein Expr. Purif. 2004, 38, 1–8. [Google Scholar] [CrossRef] [PubMed]
  74. Wally, O.; Punja, Z.K. Genetic engineering for increasing fungal and bacterial disease resistance in crop plants. GM Crops 2010, 1, 199–206. [Google Scholar] [CrossRef] [PubMed]
  75. Safari, F.; Zare, K.; Negahdaripour, M.; Barekati-Mowahed, M.; Ghasemi, Y. CRISPR Cpf1 proteins: Structure, function and implications for genome editing. Cell Biosci. 2019, 9, 36. [Google Scholar] [CrossRef] [PubMed]
  76. Chiarella, A.M.; Butler, K.V.; Gryder, B.E.; Lu, D.; Wang, T.A.; Yu, X.; Pomella, S.; Khan, J.; Jin, J.; Hathaway, N.A. Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery. Nat. Biotechnol. 2020, 38, 50–55. [Google Scholar] [CrossRef]
  77. Gamboa, L.; Phung, E.V.; Li, H.; Meyers, J.P.; Hart, A.C.; Miller, I.C.; Kwong, G.A. Heat-Triggered Remote Control of CRISPR-dCas9 for Tunable Transcriptional Modulation. ACS Chem. Biol. 2020, 15, 533–542. [Google Scholar] [CrossRef]
  78. Ochoa-Fernandez, R.; Abel, N.B.; Wieland, F.-G.; Schlegel, J.; Koch, L.-A.; Miller, J.B.; Engesser, R.; Giuriani, G.; Brandl, S.M.; Timmer, J.; et al. Optogenetic control of gene expression in plants in the presence of ambient white light. Nat. Methods 2020, 17, 717–725. [Google Scholar] [CrossRef]
  79. Li, J.; Manghwar, H.; Sun, L.; Wang, P.; Wang, G.; Sheng, H.; Zhang, J.; Liu, H.; Qin, L.; Rui, H.; et al. Whole genome sequencing reveals rare off-target mutations and considerable inherent genetic or/and somaclonal variations in CRISPR /Cas9-edited cotton plants. Plant Biotechnol. J. 2017, 17, 858–868. [Google Scholar] [CrossRef]
  80. Mccarty, N.S.; Graham, A.E.; Studená, L.; Ledesma-Amaro, R. Multiplexed CRISPR technologies for gene editing and transcriptional regulation. Nat. Commun. 2020, 11, 1281. [Google Scholar] [CrossRef]
  81. Zhang, S.; Voigt, C.A. Engineered dCas9 with reduced toxicity in bacteria: Implications for genetic circuit design. Nucleic Acids Res. 2018, 46, 11115–11125. [Google Scholar] [CrossRef]
  82. Mao, Y.; Yang, X.; Zhou, Y.; Zhang, Z.; Botella, J.R.; Zhu, J.-K. Manipulating plant RNA-silencing pathways to improve the gene editing efficiency of CRISPR/Cas9 systems. Genome Biol. 2018, 19, 149. [Google Scholar] [CrossRef]
  83. Hu, D.; Yu, Y.; Wang, C.; Long, Y.; Liu, Y.; Feng, L.; Lu, D.; Liu, B.; Jia, J.; Xia, R.; et al. Multiplex CRISPR-Cas9 editing of DNA methyltransferases in rice uncovers a class of non-CG methylation specific for GC-rich regions. Plant Cell. 2021, 33, 2950. [Google Scholar] [CrossRef] [PubMed]
  84. DeNizio, J.E.; Schutsky, E.K.; Berrios, K.N.; Liu, M.Y.; Kohli, R.M. Harnessing natural DNA modifying activities for editing of the genome and epigenome. Curr. Opin. Chem. Biol. 2018, 45, 10–17. [Google Scholar] [CrossRef] [PubMed]
  85. Qin, Y.; Sun, M.; Li, W.; Xu, M.; Shao, L.; Liu, Y.; Zhao, G.; Liu, Z.; Xu, Z.; You, J.; et al. Single-cell RNA -seq reveals fate determination control of an individual fiber cell initiation in cotton (Gossypium hirsutum). Plant Biotechnol. J. 2022. [Google Scholar] [CrossRef] [PubMed]
  86. Xu, Z.; Wang, Q.; Zhu, X.; Wang, G.; Qin, Y.; Ding, F.; Tu, L.; Daniell, H.; Zhang, X.; Jin, S. Plant Single Cell Transcriptome Hub (PsctH): An integrated online tool to explore the plant single-cell transcriptome landscape. Plant Biotechnol. J. 2021, 20, 10–12. [Google Scholar] [CrossRef] [PubMed]
Cells 11 03045 g001 550
Figure 1. Characteristics of different types of CRISPR/Cas systems. CRISPR/Cas systems are classified as types I to VI. Type I systems are characterized based on the occurrence of signature protein Cas3, a protein which contains both DNase and helicase domains used to degrade the target. Type II CRISPR/Cas systems use Cas1, Cas2, Cas9, and a fourth protein (Csn2 or Cas4), whereas the type III CRISPR/Cas systems comprise the Cas10 with an indistinct role. The type II CRISPR/Cas system originates from S. pyogenes and comprises three components: the CRISPR RNA (crRNA), trans-activating crRNA (tracrRNA), and a Cas9 protein. The type V CRISPR/Cas system (Cas12) is an RNA-guided system which is analogous to CRISPR/Cas9 but exhibits some unique characteristics. This CRISPR system relies on a T-rich sequence at the 5′-end of the protospacer sequence (5′-TTTN-3′ or 5′-TTTV-3′; V = A, C, or G, in some cases), as opposed to the G-rich, NGG sequence for Cas9. The type VI system (Cas13) is effector protein for RNA cutting, which is used as RNA-guided ribonuclease, the nonspecific, trans-acting RNase activity of which is activated by base pairing of the crRNA guide to an ssRNA target. The Cas7, Cas5,SS*, Cas8(LS), Cas10 and CSf1(LS) have been drew with different colors, but they all belong to interference part of class I.
Figure 1. Characteristics of different types of CRISPR/Cas systems. CRISPR/Cas systems are classified as types I to VI. Type I systems are characterized based on the occurrence of signature protein Cas3, a protein which contains both DNase and helicase domains used to degrade the target. Type II CRISPR/Cas systems use Cas1, Cas2, Cas9, and a fourth protein (Csn2 or Cas4), whereas the type III CRISPR/Cas systems comprise the Cas10 with an indistinct role. The type II CRISPR/Cas system originates from S. pyogenes and comprises three components: the CRISPR RNA (crRNA), trans-activating crRNA (tracrRNA), and a Cas9 protein. The type V CRISPR/Cas system (Cas12) is an RNA-guided system which is analogous to CRISPR/Cas9 but exhibits some unique characteristics. This CRISPR system relies on a T-rich sequence at the 5′-end of the protospacer sequence (5′-TTTN-3′ or 5′-TTTV-3′; V = A, C, or G, in some cases), as opposed to the G-rich, NGG sequence for Cas9. The type VI system (Cas13) is effector protein for RNA cutting, which is used as RNA-guided ribonuclease, the nonspecific, trans-acting RNase activity of which is activated by base pairing of the crRNA guide to an ssRNA target. The Cas7, Cas5,SS*, Cas8(LS), Cas10 and CSf1(LS) have been drew with different colors, but they all belong to interference part of class I.
Cells 11 03045 g001
Cells 11 03045 g002 550
Figure 2. The diagram of CRISPR/dCas9-mediated transcriptional regulation. The dCas9 fused with transcriptional inhibitors or activators can provide additional inhibition (CRISPRi) or activation (CRISPRa) functions.
Figure 2. The diagram of CRISPR/dCas9-mediated transcriptional regulation. The dCas9 fused with transcriptional inhibitors or activators can provide additional inhibition (CRISPRi) or activation (CRISPRa) functions.
Cells 11 03045 g002
Cells 11 03045 g003 550
Figure 3. Schematic diagram of CRISPR transcriptional regulation. (A) SunTag system: dCas9 fused with GCN4 to recruit multiple copies of scFv, TET and other element X to activate the target gene cooperatively; (B) dCas9-VPR system: dCas9 fused with VP64-p65-Rta to activate the target gene; (C) dCas9-TV system: dCas9 TV activation system includes 6 TAL and 2 VP128; (D) scRNA system: An RNA hairpin domain with RNA sequences MS2, PP7 and com recognized by MCP, PCP and com RNA binding proteins was introduced at the end of sgRNA, and the transcription activating element VP64 was fused into each corresponding RNA binding protein; (E) SAM system: The four bases at the distal end of the stem loops of gRNA were modified to recognize the stem loops of MS2 to bind p65 and HSF1; (F) CRISPR-Act2.0 system: dCas9 was fused with VP64 and the four bases at the distal end of the stem loops of gRNA were modified to recognize the stem loops of MS2 to bind VP64; (G) CRISPR-Act3.0 system: SunTag system with the MS2–MCP interaction would recruit more activator.
Figure 3. Schematic diagram of CRISPR transcriptional regulation. (A) SunTag system: dCas9 fused with GCN4 to recruit multiple copies of scFv, TET and other element X to activate the target gene cooperatively; (B) dCas9-VPR system: dCas9 fused with VP64-p65-Rta to activate the target gene; (C) dCas9-TV system: dCas9 TV activation system includes 6 TAL and 2 VP128; (D) scRNA system: An RNA hairpin domain with RNA sequences MS2, PP7 and com recognized by MCP, PCP and com RNA binding proteins was introduced at the end of sgRNA, and the transcription activating element VP64 was fused into each corresponding RNA binding protein; (E) SAM system: The four bases at the distal end of the stem loops of gRNA were modified to recognize the stem loops of MS2 to bind p65 and HSF1; (F) CRISPR-Act2.0 system: dCas9 was fused with VP64 and the four bases at the distal end of the stem loops of gRNA were modified to recognize the stem loops of MS2 to bind VP64; (G) CRISPR-Act3.0 system: SunTag system with the MS2–MCP interaction would recruit more activator.
Cells 11 03045 g003
Table
Table 1. Applications of CRISPR interference in plants.
Table 1. Applications of CRISPR interference in plants.
RepressorPlant SpeciesTarget GeneHighest Repression
Level (%) 		References
dCas9N. benthamianaPDS20(Piatek et al., 2015)
pNOS::LUC reporter 80(Vazquez-Vilar et al., 2016)
dCas9-SRDXN. benthamianaPDS33(Piatek et al., 2015)
pNOS::LUC reporter 50(Vazquez-Vilar et al., 2016)
Z. maysChlH75(Irene et al., 2020)
Z. maysPDS60
dCas9-BRDN. benthamianapNOS::LUC reporter 60(Vazquez-Vilar et al., 2016)
dCas9-3 × SRDXA. thalianaCSTF6460(Lowder et al., 2015)
miR159a80
miR159b70
dLbCpf1-SRDXA. thalianamiR159b90(Tang et al., 2017)
dAsCpf1-SRDXA. thalianamiR159b90
Table
Table 2. Applications of the CRISPR-activation system in plants.
Table 2. Applications of the CRISPR-activation system in plants.
ActivatorPlant SpeciesTarget GeneFold Change
(Highest Level)		References
dCas9-EDLLN. benthamianaNbPDS3.5(Piatek et al., 2015)
pNOS::LUC reporter2.2(Vazquez-vilar et al., 2016)
dCas9-TALN. benthamianaAtPDS4(Piatek et al., 2015)
dCas9-VP64A.thalianaAtPAP17(Lowder et al., 2015)
miR3197.5
AtFIS2400
N. benthamianapNOS::LUC reporter2.3(Vazquez-vilar et al., 2016)
A.thalianaAtWRKY302.1(Li et al., 2017)
AtRLP230.9
AtCDG14.3
O. sativaOsGW72.7
OsER10.3
Os03g012402.1(Lowder et al., 2018)
Os04g397801.1
Os11g354102.2
Z. maysPDS2.5(Irene et al., 2020)
TrxH2.0
dCas9-VP64  + MS2-p65-HSF1 (SAM)A.thalianaAtAVP15(Park et al., 2017)
AtPAP17
dCas9-4 × EE-2 × VP64A.thalianapWRKY30::LUC reporter12.6(Li et al., 2017)
dCas9-6 × TAL-2 × VP64 (dCas9-TV)A.thalianaAtWRKY30138.8(Li et al., 2017)
AtRLP2332.3
AtCDG192.2
Oryza sativaOsGW778.8
OsER162
dCpf1-TVA.thalianapWRKY30::LUC reporter4.7(Li et al., 2017)
dCas9-VP64-EDLLA.thalianaAtPAP14(Lowder et al., 2018)
AtFIS23
O. sativaOsCGA15(Lee et al., 2021)
dCas9-VP64 + MS2-EDLLA.thalianaAtPAP130(Lowder et al., 2018)
AtFIS230
dCas9-VP64  + MS2-VP64
(CRISPR-Act2.0)		A.thalianaAtPAP145(Lowder et al., 2018)
AtFIS21500
AtULC140
miR3196
O. sativaOs03g012403
Os04g397804
Os11g354102.8
dCas9-2 × GCN4 + scFv-sfGFP-VP64 (SunTag)A.thalianaAtFWA140(Papikian et al., 2019)
AtEVD4000
AtAP3350
AtCLV3130
dCasEV2.1
(EDLL-MS2:VPR/gRNA2.1)		N. benthamianaNbAN24000(Selma et al., 2019)
NbDFR10000
NbPAL400(Selma et al., 2022)
NbC4H4
Nb4CL15
NbCHS18000
NbCHI45
NbF3H140
NbFLS40
dCas9-TVO. sativaOsER1
OsGW7		4000
200		(Xiong et al., 2021)
Gossypium hirsutumGhpapid41.7(unpublished data)
Ghaepsp16
CRISPR-Act3.0
gR2.0 4xGCN4		O. sativaOsGW745(Pan et al., 2021)
OsER190
CRISPR-Act3.0
gR2.0 10xGCN4		OsGW770
OsER195
CRISPR-Act3.0
gR8xMS2 4xGCN4		OsGW745
OsER140
CRISPR-Act3.0
gR8xMS210xGCN4		OsGW715
OsER110
CRISPR-Act3.0
VP64 4xGCN4		OsER130
CRISPR-Act3.0
VP64 10xGCN4		90
CRISPR-Act3.0
2xTAD 4xGCN4		140
CRISPR-Act3.0
2xTAD 10xGCN4		250
CRISPR-Act3.0
2xTAD–VP64 4xGCN4		120
CRISPR-Act3.0
2xTAD–VP64 10xGCN4		50
CRISPR-Act3.0
TV 4xGCN4		35
CRISPR-Act3.0
TV 10xGCN4		25
CRISPR-Act3.0
VPR 4xGCN4		30
CRISPR-Act3.0
VPR 10xGCN4		45
M-Act3.0
(Multiple sgRNAs)		OsDXS9
OsPDS6
OsPSY17
OsCRTISO3
OsZISO23
OsZDS3.5
OsCYB11
OsCHS30
OsCHI2
OsF3H130
OsDFR20
OsLAR70
A.thalianaAtFT240
AtTCL18
AtEVD4000
AtAP3350
AtCLV3130
Lycopersicon esculentumLeSFT240
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ding, X.; Yu, L.; Chen, L.; Li, Y.; Zhang, J.; Sheng, H.; Ren, Z.; Li, Y.; Yu, X.; Jin, S.; et al. Recent Progress and Future Prospect of CRISPR/Cas-Derived Transcription Activation (CRISPRa) System in Plants. Cells 2022, 11, 3045. https://doi.org/10.3390/cells11193045

AMA Style

Ding X, Yu L, Chen L, Li Y, Zhang J, Sheng H, Ren Z, Li Y, Yu X, Jin S, et al. Recent Progress and Future Prospect of CRISPR/Cas-Derived Transcription Activation (CRISPRa) System in Plants. Cells. 2022; 11(19):3045. https://doi.org/10.3390/cells11193045

Chicago/Turabian Style

Ding, Xiao, Lu Yu, Luo Chen, Yujie Li, Jinlun Zhang, Hanyan Sheng, Zhengwei Ren, Yunlong Li, Xiaohan Yu, Shuangxia Jin, and et al. 2022. "Recent Progress and Future Prospect of CRISPR/Cas-Derived Transcription Activation (CRISPRa) System in Plants" Cells 11, no. 19: 3045. https://doi.org/10.3390/cells11193045

APA Style

Ding, X., Yu, L., Chen, L., Li, Y., Zhang, J., Sheng, H., Ren, Z., Li, Y., Yu, X., Jin, S., & Cao, J. (2022). Recent Progress and Future Prospect of CRISPR/Cas-Derived Transcription Activation (CRISPRa) System in Plants. Cells, 11(19), 3045. https://doi.org/10.3390/cells11193045

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop